id: pfos_serum_concentration_to_hormone_receptor_positive_breast_cancer
name: Serum Perfluorooctane Sulfonate (PFOS) Concentration â†’ Hormone Receptor Positive
  Breast Cancer (ER+/PR+)
from_node:
  node_id: pfos_serum_concentration
  node_name: Serum Perfluorooctane Sulfonate (PFOS) Concentration
to_node:
  node_id: hormone_receptor_positive_breast_cancer
  node_name: Hormone Receptor Positive Breast Cancer (ER+/PR+)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: PFOS acts as an endocrine-disrupting chemical that interferes with hormonal
  signaling pathways'
- 'Step 2: Disruption of estrogen and progesterone receptor pathways promotes cellular
  proliferation in hormone-sensitive breast tissue'
- 'Step 3: Persistent exposure to PFOS through contaminated water, food, and consumer
  products leads to sustained endocrine disruption'
- 'Step 4: Accumulated endocrine disruption increases risk of hormone receptor-positive
  tumor development in postmenopausal women'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'V. Chang et al. 2023. "Serum perfluorooctane sulfonate and perfluorooctanoate
    and risk of postmenopausal breast cancer according to hormone receptor status:
    An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial."
    *International Journal of Cancer*. https://doi.org/10.1002/ijc.34487'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.488846'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: hormone_receptor_status
  direction: strengthens
  strength: strong
  description: PFOS association specifically elevated for ER+/PR+ tumors (OR=2.19,
    95% CI 1.21-3.98) but not for overall breast cancer risk, suggesting hormonal
    pathway-specific mechanism
- name: exposure_quartile
  direction: u_shaped
  strength: moderate
  description: Third quartile showed strongest association with ER+/PR+ tumors (OR=2.19),
    while fourth quartile showed elevated but non-statistically significant ORs, suggesting
    possible non-linear dose-response
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/pfos_serum_concentration_to_hormone_receptor_positive_breast_cancer.yaml
_category: biological
